Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-07-19FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for a generic duloxetine product (ANDA204343). Duloxetine is indicated for major depr…
-
FDA approval · 2018-06-12FDA Approved: PAROXETINE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved the original abbreviated new drug application for paroxetine hydrochloride hemihydrate from Rhodes Pharmaceuticals, establishin…
-
FDA approval · 2018-06-08FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's Bupropion hydrochloride as a generic drug under an Original Application (ANDA). The product i…
-
FDA approval · 2018-05-08FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
The FDA approves Accord Healthcare, Inc.'s supplemental application for sertraline hydrochloride (sertraline HCl).
-
FDA approval · 2018-05-02FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for TRINTELLIX (vortioxetine) submitted by Takeda Pharmaceuticals America, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-04-17FDA Approved: TRANYLCYPROMINE — Original Application (Novitium Pharma LLC)
FDA approved Novitium Pharma LLC's original ANDA for Tranylcypromine, a generic monoamine oxidase inhibitor for major depressive disorder.
-
FDA approval · 2018-02-06FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental NDA for PRISTIQ EXTENDED-RELEASE (desvenlafaxine succinate) from Wyeth Pharmaceuticals (Pfizer), approving the e…
-
FDA approval · 2018-01-04FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Tranylcypromine sulfate by Actavis Pharma, Inc., resulting in updated labeling for the product.
-
FDA approval · 2017-12-26FDA Approved: DESIPRAMINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Desipramine Hydrochloride as an Original Application ANDA by Ingenus Pharmaceuticals, LLC, providing a generic version of the a…
-
FDA approval · 2017-12-19FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2017-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC.
-
FDA approval · 2017-12-19FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for desvenlafaxine from Sun Pharmaceutical Industries, updating the drug's approval in some mann…
-
FDA approval · 2017-12-19FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2017-12-19FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to introduce an extended-release formulation of Pristiq (desvenlafaxine succinate) from Wyeth Pharma…
-
FDA approval · 2017-12-14FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Solco Healthcare US LLC)
FDA approved a supplemental application for a generic formulation of bupropion hydrochloride sustained-release (SR) by Solco Healthcare US L…
-
FDA approval · 2017-12-11FDA Approved: ARIPIPRAZOLE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's ARIPIPRAZOLE as an original application generic, allowing marketing for the same indications as the reference prod…
-
FDA approval · 2017-12-08FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride submitted by Mylan Pharmaceuticals, likely affecting the product la…
-
FDA approval · 2017-12-04FDA Approved: ARIPIPRAZOLE — Original Application (Solco Healthcare U.S., LLC)
FDA approved ARIPIPRAZOLE from Solco Healthcare U.S., LLC as an original generic application. The approval allows generic aripiprazole for t…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic quetiapine under an Original Application (ANDA204253), making a generic version of q…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
FDA approved a generic quetiapine fumarate product from Accord Healthcare Inc. under an original ANDA.
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' quetiapine fumarate under an Original Application, making a generic version of the antipsychotic avail…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic quetiapine fumarate product from Aurobindo Pharma Limited. Quetiapine is used to treat s…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE EXTENDED RELEASE — Original Application (ACI Healthcare USA, Inc.)
FDA approved an original application for quetiapine extended-release (generic) by ACI Healthcare USA, Inc., making a generic version of quet…
-
FDA approval · 2017-11-20FDA Approved: FLUOXETINE — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approved NIVAGEN Pharmaceuticals' original application for fluoxetine hydrochloride, granting marketing approval for a generic version o…
-
FDA approval · 2017-11-16FDA Approved: FLUOXETINE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s original application for a generic fluoxetine product.